Hims & Hers is bringing access to its Weight Loss Program to customers in the UK. This expansion includes the official introduction of the Hers platform, helping eligible women across the UK receive access to this weight management care. Following an intake assessment conducted by GMC-registered doctors, eligible customers now have access to transparent pricing and weight management programs, which may include branded GLP-1 options, such as Mounjaro or Wegovy, and the oral non-prescription treatment option, Orlos.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HIMS:
- Mixed options sentiment in Hims and Hers Health with shares up 1.56%
- HIMS Stock Forecast: Barclays Initiates With Buy Rating, Sees Over 20% Upside
- Barclays starts Hims & Hers at Overweight, says expectations are more reasonable
- Hims & Hers initiated with an Overweight at Barclays
- Hims & Hers announces entry into Canada